News

Read More › about J&J blood clot risk is less than 1 in a million. Don’t be skeptical about the vaccine, docs say.

Read More › about Conversations with CABM Director: An interview with Dr. Martin Blaser

Read More › about Life in N.J. will never be the same after COVID. Here’s what ‘new normal’ could look like.

Read More › about Infant Antibiotic Exposure Can Affect Future Immune Responses Toward Allergies

Read More › about 15M Johnson & Johnson vaccine doses ruined in manufacturing error

Read More › about Conversations with CABM Director: An interview with Dr. Anat Kreimer

Read More › about Conversations with CABM Director: An interview with Dr. Alexander Valvezan

Read More › about NJ’s prospects for reaching herd immunity to the coronavirus?

Read More › about Conversations with CABM Director: An interview with Dr. Hiroko Nobuta